Page last updated: 2024-08-25

bexarotene and Neutropenia

bexarotene has been researched along with Neutropenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, T; Iwatsuki, K; Kawai, K; Kiyohara, E; Matsushita, S; Nagatani, T; Ohtsuka, M; Saida, T; Setoyama, M; Sugaya, M; Tani, M; Tokura, Y; Tsuboi, R; Yonekura, K1
Hahtola, S; Ranki, A; Väkevä, L1

Trials

1 trial(s) available for bexarotene and Neutropenia

ArticleYear
Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).
    The Journal of dermatology, 2019, Volume: 46, Issue:7

    Topics: Adult; Antineoplastic Agents; Bexarotene; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypothyroidism; Japan; Leukopenia; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Mycosis Fungoides; Neoplasm Staging; Neutropenia; Skin Neoplasms; Time Factors; Young Adult

2019

Other Studies

1 other study(ies) available for bexarotene and Neutropenia

ArticleYear
Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anticarcinogenic Agents; Aspartate Aminotransferases; Bexarotene; Combined Modality Therapy; Finland; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypothyroidism; Liver; Lymphoma, T-Cell, Cutaneous; Middle Aged; Neoplasm Staging; Neutropenia; Retrospective Studies; Skin Neoplasms; Tetrahydronaphthalenes

2012